Cargando…
Sensitivity towards HDAC inhibition is associated with RTK/MAPK pathway activation in gastric cancer
Gastric cancer ranks the fifth most common and third leading cause of cancer‐related deaths worldwide. Alterations in the RTK/MAPK, WNT, cell adhesion, TP53, TGFβ, NOTCH, and NFκB signaling pathways could be identified as main oncogenic drivers. A combination of altered pathways can be associated wi...
Autores principales: | Seidlitz, Therese, Schmäche, Tim, Garcίa, Fernando, Lee, Joon Ho, Qin, Nan, Kochall, Susan, Fohgrub, Juliane, Pauck, David, Rothe, Alexander, Koo, Bon‐Kyoung, Weitz, Jürgen, Remke, Marc, Muñoz, Javier, Stange, Daniel E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549728/ https://www.ncbi.nlm.nih.gov/pubmed/35993110 http://dx.doi.org/10.15252/emmm.202215705 |
Ejemplares similares
-
Gastric organoids—an in vitro model system for the study of gastric development and road to personalized medicine
por: Seidlitz, Therese, et al.
Publicado: (2020) -
Correction: Gastric organoids—an in vitro model system for the study of gastric development and road to personalized medicine
por: Seidlitz, Therese, et al.
Publicado: (2021) -
Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations
por: Seidlitz, Therese, et al.
Publicado: (2019) -
The Design and Synthesis of a New Class of RTK/HDAC Dual-Targeted Inhibitors
por: Zhang, Xuan, et al.
Publicado: (2013) -
Spotlight on Accessory Proteins: RTK-RAS-MAPK Modulators as New Therapeutic Targets
por: Pudewell, Silke, et al.
Publicado: (2021)